ACE2 and pulmonary arterial hypertension: In the PAH+A group, the ACE2 expression at the protein level determined by Western blot and immunohistochemistry was maintained at the same level as the control group, preventing the PAH-induced overexpression (Figure 4a,b) (p < 0.05).